EBASTINE TEVA GROUP 20 mg FILM-COATED TABLETS
How to use EBASTINE TEVA GROUP 20 mg FILM-COATED TABLETS
Translated with AI
This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.
Show originalContents of the leaflet
Introduction
Package Leaflet: Information for the User
Ebastine Teva Group 20 mg film-coated tablets EFG
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist.
- Keep this package leaflet, as you may need to read it again.
- If you need advice or more information, consult your pharmacist.
- If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. See section 4.
- You should consult a doctor if your symptoms worsen or do not improve after 7 days of treatment.
Contents of the Package Leaflet:
- What Ebastine Teva Group is and what it is used for
- What you need to know before taking Ebastine Teva Group
- How to take Ebastine Teva Group
- Possible side effects
- Storage of Ebastine Teva Group
- Package contents and additional information
1. What Ebastine Teva Group is and what it is used for
Ebastine belongs to a group of medications called antihistamines (anti-allergics).
This medication is used to relieve nasal symptoms (sneezing, nasal itching, nasal discharge, nasal congestion) and eye symptoms (red and watery eyes) associated with seasonal and perennial allergic rhinitis, for adults and adolescents over 12 years old, when a dose of 10 mg is not sufficient.
You should consult a doctor if your symptoms worsen or do not improve after 7 days.
2. What you need to know before taking Ebastine Teva Group
Do not take Ebastine Teva Group
- if you are allergic to ebastine or any of the other components of this medication (listed in section 6).
Warnings and precautions
Consult your doctor or pharmacist before starting to take Ebastine Teva Group:
- if your electrocardiogram results are altered (prolongation of the QT interval).
- if you have high potassium levels in your blood.
- if you suffer from severe liver disease (see "How to take Ebastine Teva Group").
- if you are being treated with a type of medication used to treat fungal infections called azole antifungals or with medications used to treat certain infections called macrolide antibiotics (see "Taking Ebastine Teva Group with other medications").
- if you are being treated with rifampicin, a type of medication used to treat tuberculosis.
Do not use this medication if you have an acute allergic emergency, as ebastine (the active ingredient of this medication) takes 1 to 3 hours to take effect.
If you experience symptoms such as throat tightness, difficulty breathing, hoarseness, or difficulty speaking, wheezing, low blood pressure, repeated vomiting, and/or loss of consciousness, you should seek urgent medical attention due to the risk of anaphylaxis.
Children
Ebastine Teva Group should not be administered to children under 12 years old.
Taking Ebastine Teva Group with other medications
Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
The medications listed below may interfere with ebastine; in these cases, it may be necessary to change the dose or interrupt treatment with one of them:
- Ebastine may increase the effect of other medications used to treat allergies (antihistamines).
- Ebastine should be used with caution in patients being treated with medications called ketoconazole and itraconazole, used to treat fungal infections, or with an antibiotic used to treat certain infections called erythromycin (as they may cause an alteration in the electrocardiogram).
- The antihistamine effect of ebastine may be reduced in patients being treated with a medication called rifampicin, used to treat tuberculosis.
No interactions have been described between ebastine and theophylline, warfarin, cimetidine, diazepam, and alcohol.
Interference with diagnostic tests
Ebastine may interfere with the results of skin allergy tests, so it is recommended not to perform them until 5 to 7 days after treatment has been discontinued.
Taking Ebastine Teva Group with food and beverages
This medication can be taken with or without food.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
There is no experience in pregnant women, so it is recommended to consult a doctor before taking ebastine. The doctor will decide whether or not to start treatment.
Breastfeeding
It is unknown whether the medication passes into breast milk, so it should not be used during breastfeeding.
Driving and using machines
In humans, no effects have been observed on psychomotor function or the ability to drive or use machines at the recommended therapeutic doses. However, since drowsiness and dizziness are among the side effects, observe your response to the medication before driving or using machines.
Ebastine Teva Group contains lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
3. How to take Ebastine Teva Group
Follow the administration instructions for this medication contained in this package leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
Dosage
Use in adults and adolescents over 12 years old:
The recommended dose is 10 mg of ebastine once a day, although some patients may need a dose of 1 tablet of 20 mg once a day.
Use in patients with severe liver disease:
The dose should not exceed 10 mg of ebastine per day. In this case, it is recommended to use the 10 mg presentation (ebastine 10 mg tablets).
Method of administration
This medication is for oral administration.
The tablets can be taken with or without food, with the help of a glass of water.
If you take more Ebastine Teva Group than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested. Bring the remaining tablets, the box, and the complete package so that healthcare personnel can more easily identify the medication you have taken.
If you forget to take Ebastine Teva Group
Do not take a double dose to make up for forgotten doses. Take the forgotten dose when you remember and then follow your regular schedule. However, if it is almost time for your next dose, do not take the forgotten dose and wait for your next scheduled dose.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
4. Possible side effects
Like all medications, this medication can cause side effects, although not everyone experiences them.
The following side effects have been observed in clinical trials and post-marketing experience:
Very common (may affect more than 1 in 10 people):
- headache.
Common (may affect up to 1 in 10 people):
- drowsiness,
- dry mouth.
Rare (may affect up to 1 in 1,000 people):
- hypersensitivity reactions: allergic reactions (such as anaphylaxis and angioedema),
- nervousness, insomnia,
- dizziness, decreased sensation or sensitivity, decreased or altered taste,
- palpitations, tachycardia,
- abdominal pain, vomiting, nausea, digestive problems,
- liver inflammation (hepatitis), reduction or obstruction of bile flow from the liver (cholestasis), abnormal liver function tests (increased transaminases, gamma-GT, alkaline phosphatase, and bilirubin),
- hives, skin rash, dermatitis,
- menstrual disorders,
- edema (swelling due to fluid accumulation), fatigue.
Frequency not known (cannot be estimated from available data):
- weight gain,
- increased appetite.
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are possible side effects not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
5. Storage of Ebastine Teva Group
Keep this medication out of sight and reach of children.
This medication does not require special storage conditions.
Do not use this medication after the expiration date shown on the package after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through wastewater or household waste. Deposit the packages and medications you no longer need at the SIGRE point in your pharmacy. If in doubt, ask your pharmacist how to dispose of packages and medications you no longer need. This will help protect the environment.
6. Package contents and additional information
Composition of Ebastine Teva Group
- The active ingredient is ebastine. Each tablet contains 20 mg of ebastine.
- The other components (excipients) are: lactose monohydrate, microcrystalline cellulose, pregelatinized corn starch, povidone 30, polysorbate 80, magnesium stearate, hypromellose, titanium dioxide (E171), and glycerol triacetate.
Appearance of the product and package contents
Ebastine Teva Group is presented in the form of white, lenticular-shaped film-coated tablets. Each PVC/Aluminum blister pack contains 20 tablets.
Marketing authorization holder and manufacturer
Marketing authorization holder
Teva Pharma, S.L.U. C/ Anabel Segura, 11 Edificio Albatros B 1ª planta
Alcobendas 28108, Madrid (Spain)
Manufacturer
Laboratorios Alter, S.A.
Mateo Inurria, 30
28036 Madrid (Spain)
Date of the last revision of this package leaflet:December 2022
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es
- Country of registration
- Active substance
- Prescription requiredNo
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to EBASTINE TEVA GROUP 20 mg FILM-COATED TABLETSDosage form: TABLET, 10 mg ebastineActive substance: ebastineManufacturer: Laboratorios Almirall S.L.Prescription not requiredDosage form: ORALLY DISINTEGRATING TABLET/LIOTAB, 10 mgActive substance: ebastineManufacturer: Laboratorios Almirall S.L.Prescription not requiredDosage form: TABLET, 20 mg ebastineActive substance: ebastineManufacturer: Laboratorios Almirall S.L.Prescription not required
Online doctors for EBASTINE TEVA GROUP 20 mg FILM-COATED TABLETS
Discuss questions about EBASTINE TEVA GROUP 20 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Frequently Asked Questions
